336 results
Page 2 of 17
6-K
EX-99.1
os20dow2ei y0v
18 Aug 16
First Intravenous Anti-IL-5 Biologic Therapy for Severe Eosinophilic Asthma Now Approved in Europe
12:00am
6-K
4dwax8sop19pk
20 Jul 16
Current report (foreign)
12:00am
424B5
s8zkrydtpj
18 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
ramj0z5e ni4
10 Jun 16
Teva Announces Favorable Court Ruling in TREANDA® (bendamustine hydrochloride) Patent Infringement Litigation
12:00am
6-K
EX-99.1
4owy 3sd79uocwbua9m
18 Apr 16
First-HD Study shows improvements in Total Motor Score and Swallowing Function in Huntington disease patients treated with SD-809
12:00am
6-K
EX-99.1
3v7n74i
12 Apr 16
Teva to Present Data Highlighting Company’s Pipeline in Neurological Disorders at 68th AAN Annual Meeting
12:00am
424B5
zud 5tphp
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
bf6gyxp9sl1mt idud
30 Nov 15
Current report (foreign)
12:00am
424B5
gdbzbzqwf efm24v
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
bk9xmjw f50air
30 Nov 15
Current report (foreign)
12:00am
6-K
EX-99.1
75n4q3d6l9zbvknngw
30 Sep 15
IMPORTANT NEW DATA FROM TEVA’S TEV-48125 PHASE 2b MIGRAINE PROGRAM PUBLISHED INLANCET NEUROLOGYIN BACK-TO-BACK ARTICLES
12:00am
6-K
EX-99.1
5aewl2o5t 0ikeltzqu
28 Sep 15
Teva Announces Approval of COPAXONE® in Japan for the Prevention of Relapse of Multiple Sclerosis
12:00am
6-K
EX-99.1
fveei9
28 Sep 15
Teva Presents New Reslizumab Data at European Respiratory Society (ERS) International Congress 2015
12:00am
6-K
EX-99.1
vgzajv66s
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
6-K
EX-99.3
sdv6g
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
425
s6xu8550b3
21 Apr 15
Business combination disclosure
12:00am
6-K
EX-99.1
ktuz264a19jkpg57nd
23 Mar 15
Live Filing
12:00am
6-K
EX-99.1
09tqjgr00t7weqq
23 Mar 15
Teva Announces New Head of Business Development, Strategy and Innovation
12:00am
6-K
EX-99.1
dkxirtd7sn26ovv
2 Mar 15
Teva Announces Sale of Sellersville, PA Facility
12:00am